Smiths Medical to distribute new carbon dioxide absorbent used in anesthesia delivery

By E. Janene Geiss

Philadelphia, Aug. 11 - Smiths Medical announced Friday the launch of its exclusive distribution in the United States of a new carbon dioxide absorbent for delivery of anesthesia at low flow rates.

Sodasorb LF Carbon Dioxide Absorbent, manufactured by W. R. Grace & Co., is a new generation carbon dioxide absorbent that makes modern, closed-circuit low flow anesthesia techniques safer, more efficient, and cost effective, according to a company news release.

Anesthesiologists, technicians and medical facilities around the world are rapidly adopting more economical closed- and semi-closed low flow methods of administering inhalation anesthetic. Effective carbon dioxide absorption during this type of anesthesia delivery is critical in preventing problematic gaseous byproducts that may result, officials said.

Featuring an original patented formulation that inhibits the degradation of anesthetic gases, the Sodasorb LF Carbon Dioxide Absorbent eliminates the potential for those dangerous byproducts associated with absorbents under low flow rate conditions, officials said.

The new Sodasorb is not only more efficient at carbon dioxide absorption at low flow rates, it also features a permanent color change from white to violet as the product is exhausted or in the event of desiccation, thus alerting users as to the appropriate time to change out the product, officials said.

Smiths Medical is a maker of medical devices used for therapeutic, diagnostic and surgical procedures. Its parent company is Smiths Group plc, a London engineering company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.